Tucatinib versus placebo added to trastuzumab and capecitabine for patients with previously treated HER2+ metastatic breast cancer with brain metastases (HER2CLIMB).Nancy U. Lin, Eric P. Winer, Rashmi K. Murthy et al.|Journal of Clinical Oncology|2020Cited by 12
Evorpacept plus enfortumab vedotin in patients (Pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Phase 1a dose escalation results.Samuel A. Funt, Rohit K. Jain, Tian Zhang et al.|Journal of Clinical Oncology|2024Cited by 2